|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/27/23 Healthpeak Properties, Inc. 8-K:5,9 4/27/23 11:354K Toppan Merrill/FA |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 44K 2: EX-10.1 Material Contract HTML 117K 6: R1 Cover HTML 47K 9: XML IDEA XML File -- Filing Summary XML 12K 7: XML XBRL Instance -- tm2313656d1_8k_htm XML 15K 8: EXCEL IDEA Workbook of Financial Reports XLSX 8K 4: EX-101.LAB XBRL Labels -- hcp-20230427_lab XML 96K 5: EX-101.PRE XBRL Presentations -- hcp-20230427_pre XML 64K 3: EX-101.SCH XBRL Schema -- hcp-20230427 XSD 12K 10: JSON XBRL Instance as JSON Data -- MetaLinks 25± 34K 11: ZIP XBRL Zipped Folder -- 0001104659-23-051395-xbrl Zip 47K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
(Exact name of registrant as specified in its charter)
| i Maryland | i 001-08895 | i 33-0091377 |
| (State or other jurisdiction of incorporation) |
(Commission File Number) | (IRS Employer Identification No.) |
i 4600 South Syracuse Street, i Suite 500
(Address of principal executive offices) (Zip Code)
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| i ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| i ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| i ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| i ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| i Common stock, $1.00 par value | i PEAK | i New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
| Item 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
2023 Performance Incentive Plan
Healthpeak Properties, Inc. (the “Company”) held its annual meeting of stockholders (the “Annual Meeting”) on April 27, 2023. At the Annual Meeting, as discussed below, the Company’s stockholders approved the 2023 Performance Incentive Plan (the “2023 Plan”). The 2023 Plan was described in the section titled “Approval of the Healthpeak Properties, Inc. 2023 Performance Incentive Plan” in the Company’s Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on March 17, 2023 (the “Proxy Statement”), which section is incorporated herein by reference. The 2023 Plan was approved, subject to stockholder approval, by the Board of Directors of the Company on February 2, 2023. In connection with stockholder approval of the 2023 Plan, the Company will no longer grant new awards under its Amended and Restated 2014 Performance Incentive Plan.
The foregoing description and the description incorporated by reference from the Proxy Statement are qualified in their entirety by reference to the 2023 Plan, a copy of which is filed as Exhibit 10.1 to this report and incorporated herein by reference.
| Item 5.07 | Submission of Matters to a Vote of Security Holders. |
At the Annual Meeting, there were present, in person or by proxy, 482,819,938 shares of the Company’s common stock, which represented approximately 88.27% of the shares entitled to vote and constituted a quorum.
Set forth below are the voting results for the five proposals considered and voted upon at the Annual Meeting, each of which were described in the Company’s Proxy Statement.
Proposal 1. All of the nominees listed below were elected to the Board of Directors of the Company, each having received the affirmative vote of a majority of the votes cast.
| For | Against | Abstain | Broker Non-Votes | % of Votes Cast Supporting | ||||||
| Scott M. Brinker | 454,024,721 | 3,612,326 | 255,283 | 24,927,608 | 99.21% | |||||
| Brian G. Cartwright | 448,474,915 | 8,150,208 | 1,267,207 | 24,927,608 | 98.22% | |||||
| James B. Connor | 455,966,627 | 1,661,176 | 264,527 | 24,927,608 | 99.64% | |||||
| Christine N. Garvey | 426,705,949 | 30,955,996 | 230,385 | 24,927,608 | 93.24% | |||||
| R. Kent Griffin, Jr. | 451,536,781 | 6,099,344 | 256,205 | 24,927,608 | 98.67% | |||||
| David B. Henry | 424,762,327 | 32,867,556 | 262,447 | 24,927,608 | 92.82% | |||||
| Sara G. Lewis | 444,995,324 | 12,668,029 | 228,977 | 24,927,608 | 97.23% | |||||
| Katherine M. Sandstrom | 449,742,657 | 7,921,963 | 227,710 | 24,927,608 | 98.27% |
Proposal 2. The advisory vote to approve 2022 executive compensation was approved.
| For | Against | Abstain | Broker Non-Votes | % of Votes Cast Supporting | ||||
| 420,443,636 | 35,511,510 | 1,937,184 | 24,927,608 | 92.21% |
Proposal 3. The frequency of future advisory votes on executive compensation was approved at “one year,” which was the frequency selected by a majority of the Company’s stockholders.
| One Year | Two Years | Three Years | Abstain | Broker Non-Votes | % of Votes Cast Supporting One Year | |||||
| 440,119,171 | 300,304 | 16,953,294 | 519,561 | 24,927,608 | 96.23% |
Based on the voting results for Proposal 3, the Company intends to include an advisory vote on executive compensation every year in its proxy materials for each annual meeting of stockholders.
Proposal 4. The 2023 Plan was approved.
| For | Against | Abstain | Broker Non-Votes | % of Votes Cast Supporting | ||||
| 415,110,863 | 42,146,593 | 634,874 | 24,927,608 | 90.78% |
Proposal 5. The ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023, was approved.
| For | Against | Abstain | Broker Non-Votes | % of Votes Cast Supporting | ||||
| 469,781,033 | 12,784,245 | 254,660 | N/A | 97.35% |
| Item 9.01. | Financial Statements and Exhibits |
(d) Exhibits
| Exhibit No. |
Description | |
| 10.1 | Healthpeak Properties, Inc. 2023 Performance Incentive Plan. | |
| 104 | The cover page of this Current Report on Form 8-K, formatted in Inline XBRL. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: April 27, 2023
| Healthpeak Properties, Inc. | ||
| By: | /s/ Jeffrey H. Miller | |
| Jeffrey H. Miller | ||
| General Counsel | ||
| This ‘8-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| 12/31/23 | ||||
| Filed on / For Period end: | 4/27/23 | 8-K | ||
| 3/17/23 | 4, ARS, DEF 14A, DEFA14A | |||
| 2/2/23 | 3, 4 | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/17/23 Healthpeak Properties, Inc. DEF 14A 13:40M Labrador Co./FA |